| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |